Danger of bacterial translocation for a surgical patient

Česká verzia

Authors: E. Havel
Authors place of work: Chirurgická klinika Fakultní nemocnice Hradec Králové a Lékařská fakulta v Hradci Králové Univerzity Karlovy
Published in the journal: Rozhl. Chir., 2021, roč. 100, č. 1, s. 4-9.
Category: Review
doi: https://doi.org/10.33699/PIS.2021.100.1.4–9

Summary

Intestinal barrier disorder manifestation occurs in connection with surgery in conditions of shock ischemia-reperfusion of the intestine or deterioration of an already damaged barrier due to chronic disease. The result is infectious complications caused by the transport of pathogens through the venous blood, most often postoperative pneumonia and sepsis. However, a more frequent manifestation is the intensification of the postoperative systemic inflammatory response through the lymphatic transport of toxic substances, inanimate antigens and cytokines through the lymphatic system of the splanchnic area (gut-lymph axis). The problem can affect up to half of patients with abdominal surgery. Preventive measures consist of strengthening the intestinal barrier before surgery and alleviating the loss of the intestinal barrier in the perioperative period. In the treatment of infectious complications, an early recognition indication for the therapeutic administration of antibiotics based on preoperative microbial screening of patients at risk may help.

Keywords:

intestinal barrier − bacterial translocation− intestinal permeability − antibiotic prophylaxis − abdominal surgery

Zdroje

Deierhoi RJ, Dawes LG, Vick C, et al. Choice of intravenous antibiotic prophylaxis for colorectal surgery does matter. J Am Coll Surg. 2013;217(5):763−769. doi:10.1016/j.jamcollsurg.2013.07.003.
Pham TN, Loupias P, Dassonville-Klimpt A, et al. Drug delivery systems designed to overcome antimicrobial resistance. Med Res Rev. 2019;39(6):2343−2396. doi:10.1002/med.21588.
Kolář M. Principles of antibiotic therapy. Rozhl Chir 2019;98(4):137−144.
Kataoka K. The intestinal microbiota and its role in human health and disease. J Med Invest. 2016;63:27−37. doi:10.2152/jmi.63.27.
Rajilić-Stojanović M, de Vos WM. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev. 2014;38(5):996−1047. doi:10.1111/1574-6976.12075.
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533. doi:10.1371/journal.pbio.1002533.
Sommer F, Anderson JM, Bharti R, et al. The resilience of the intestinal microbiota influences health and disease. Nat Rev Microbiol. 2017;15(10):630−638. doi:10.1038/nrmicro.2017.58.
Wells JM, Brummer RJ, Derrien M, et al. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol. 2017;312(3):G171−G193. doi:10.1152/ajpgi.00048.2015.
Assimakopoulos SF, Triantos C, Maroulis I, et al. The role of the gut barrier function in health and disease. Gastroenterology Res. 2018;11:261−263. doi:10.14740/gr1053w.
Assimakopoulos SF, Papageorgiou I, Charonis A. Enterocytes‘ tight junctions: From molecules to diseases. World J Gastrointest Pathophysiol. 2011;2(6):123−137. doi:10.4291/wjgp.v2.i6.123.
König J, Wells J, Cani PD, García-Ródenas CL, et al. Human intestinal barrier function in health and disease. Clin Transl Gastroenterol. 2016;7(10):e196. doi:10.1038/ctg.2016.54.
Tong J, Zheng Q, Zhang C, et al. Z. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(2):265−276; quiz 277. doi:10.1038/ajg.2014.431. Epub 2015 Jan 27. Erratum in: Am J Gastroenterol. 2015;110(7):1121. Zheng, Qinq [corrected to Zheng, Qing].
Tachecí I, Kopácová M, Rejchrt S, et al. Non-steroidal anti-inflammatory drug induced injury to the small intestine. Acta Medica (Hradec Kralove) 2010;53(1):3−11.
Whittle BJ. Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors. Eur J Pharmacol. 2004;500(1−3):427−39. doi:10.1016/j.ejphar.2004.07.042.
Mischel RA, Muchhala KH, Dewey WL, et al. The „culture“ of pain control: A review of opioid-Induced dysbiosis (OID) in antinociceptive tolerance. J Pain. 2019;11:S1526−5900(19)30877-6. doi:10.1016/j.jpain.2019.11.015.
Wang F, Li Y, Cui C, et al. Effects of anesthetics on barrier tissue function. J Immunol Res. 2019:5920620. doi:10.1155/2019/5920620.
Altshuler AE, Kistler EB, Schmid-Schönbein GW. Autodigestion: proteolytic degradation and multiple organ failure in shock. Shock 2016;45(5):483−489. doi:10.1097/SHK.0000000000000544.
Buckley A, Turner JR. Cell biology of tight junction barrier regulation and mucosal disease. Cold Spring Harb Perspect Biol. 2018;10(1):a029314. doi:10.1101/cshperspect.a029314.
Nørgaard M, Nielsen RB, Jacobsen JB, et al. Use of penicillin and other antibiotics and risk of multiple sclerosis: a population-based case-control study. Am J Epidemiol. 2011;174(8):945−948. doi:10.1093/aje/kwr201.
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn‘s disease and ulcerative colitis. Am J Gastroenterol. 2011;106(12):2133−2142. doi:10.1038/ajg.2011.304.
Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979;23(2):403−411. doi:10.1128/IAI.23.2.403-411.1979.
Knoop KA, McDonald KG, Kulkarni DH, et al. Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut 2016;65(7):1100−1109. doi:10.1136/gutjnl-2014-309059.
Knoop KA, Gustafsson JK, McDonald KG, et al. Antibiotics promote the sampling of luminal antigens and bacteria via colonic goblet cell associated antigen passages. Gut Microbes 2017;8(4):400−411. doi:10.1080/19490976.2017.1299846.
42. Carrico CJ, Meakins JL, Marshall JC, et al. Multiple-organ-failure syndrome. Arch Surg. 1986;121(2):196−208. doi:10.1001/archsurg.1986.01400020082010.
Marshall JC, Christou NV, Meakins JL. The gastrointestinal tract. The „undrained abscess“ of multiple organ failure. Ann Surg. 1993;218(2):111−119. doi:10.1097/00000658-199308000-00001.
Assimakopoulos SF, Triantos C, Thomopoulos K, et al. Gut-origin sepsis in the critically ill patient: pathophysiology and treatment. Infection 2018;46(6):751−760. doi:10.1007/s15010-018-1178-5.
Reino DC, Pisarenko V, Palange D, et al. Trauma hemorrhagic shock-induced lung injury involves a gut-lymph-induced TLR4 pathway in mice. PLoS One 2011;6(8):e14829. doi:10.1371/journal.pone.0014829.
Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002;131(3):241−244. doi:10.1067/msy.2002.116408.
Nagpal R, Yadav H. Bacterial translocation from the gut to the distant organs: An Overview. Ann Nutr Metab. 2017;71 Suppl 1:11−16. doi:10.1159/000479918.
Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007;28(10):429−436. doi:10.1016/j.it.2007.08.004.
Marik PE, Flemmer M. The immune response to surgery and trauma: Implications for treatment. J Trauma Acute Care Surg. 2012;73(4):801−808. doi:10.1097/TA.0b013e318265cf87.
Qiao Z, Li Z, Li J, et al. Bacterial translocation and change in intestinal permeability in patients after abdominal surgery. J Huazhong Univ Sci Technolog Med Sci. 2009;29(4):486−491. doi:10.1007/s11596-009-0419-3.
Altshuler AE, Kistler EB, Schmid-Schönbein GW. Autodigestion: proteolytic degradation and multiple organ failure in shock. Shock 2016;45(5):483−489. doi:10.1097/SHK.0000000000000544.
Schietroma M, Pessia B, Colozzi S, et al. Does bacterial translocation influence the postoperative infections in splenectomized patients after abdominal trauma? Surgeon 2018;16(2):94−100. doi:10.1016/j.surge.2016.09.009.
MacFie J. Enteral versus parenteral nutrition: the significance of bacterial translocation and gut-barrier function. Nutrition 2000;16(7−8):606-611. doi:10.1016/s0899-9007(00)00249-5.
Kotzampassi K, Stavrou G, Damoraki G, et al. A four-probiotics regimen reduces postoperative complications after colorectal surgery: A randomized, double-blind, placebo-controlled study. World J Surg. 2015;39(11):2776−2783. doi:10.1007/s00268-015-3071-z.
Besselink MG, van Santvoort HC, Buskens E, et al. Dutch acute pancreatitis study group. probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008;371(9613):651−659. doi:10.1016/S0140-6736(08)60207-X.
Gustafsson UO, Scott MJ, Hubner M, et al. Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS^®) society recommendations: 2018. World J Surg. 2019;43(3):659−695. doi:10.1007/s00268-018-4844-y.
Adamová Z, Slováček R, Romanová G. ERAS in colorectal surgery – neglected preadmission items. Rozhl Chir. 2019;98(9):345−349. doi:10.33699/PIS.2019.98.9.345-349.
Medeiros Ada C, Araújo-Filho I, Tôrres ML, et al. Ischemic preconditioning in different times and its effect on bacterial translocation induced by intestinal ischemia and reperfusion in rats. Rev Col Bras Cir. 2013;40(1):55−59. doi:10.1590/s0100-69912013000100010.
Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study. Chest 2017;151(6):1229−1238. doi:10.1016/j.chest.2016.11.036.
Adámková V. Role nových antibiotik u nitrobřišních infekcí v éře multirezistentních bakterií. Rozhl Chir. 2019;98(4):145−151.
Abis GSA, Stockmann HBAC, Bonjer HJ, et al. SELECT trial study group. Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial). Br J Surg. 2019;106(4):355−363. doi:10.1002/bjs.11117.